Monitoring the Responsiveness of T and Antigen Presenting Cell Compartments in Breast Cancer Patients Is Useful to Predict Clinical Tumor Response to Neoadjuvant Chemotherapy
BMC Cancer - United Kingdom
doi 10.1186/s12885-017-3982-1
Full Text
Open PDFAbstract
Available in full text
Date
January 15, 2018
Authors
Publisher
Springer Science and Business Media LLC